Drug Profile
Research programme: tuberculosis DNA vaccines - GenomIdea
Alternative Names: HVJ-Envelope/HSP65 DNA+IL-12 DNA - GenomIdeaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GenomIdea
- Class DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in Japan (Parenteral)
- 17 Sep 2011 Pharmacodynamics and immunogenicity data from a Preclinical trial in Tuberculosis presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2011)
- 15 Sep 2009 Preclinical trials in Tuberculosis in Japan (unspecified route)